Organically modified silicate coatings for optical fibers

ABSTRACT Three kinds of UV-curable organically modified silicates have been prepared to be used as protective coatings for optical fibers. The synthesis involves the reaction of the thiol group of 3-mercaptopropyltrimethoxysilane with a C =C bond in one of the acrylic groups of three commercially available aliphatic triacrylates. The methoxysilyl groups of the synthesized diacrylate methoxysilanes were subjected to hydrolysis and condensation to form Si-O-Si units. Transparent, viscous, solvent-free resins were obtained that hardened in seconds when exposed to UV radiation. The coating derived from the reaction with glycerol propoxy triacrylate (GPTA) proved to adhere the best of the three to both plastic and glass substrates. It was then tested as a protective coating for silica fibers. Reliability tests were carried out including bending strength and fatigue tests at pH 7 and 10. The results show improved water resistance of the coated fiber in neutral conditions. INTRODUCTION Present formulations for UV-curable coatings applied to protect optical fibers consist of several components. Generally, the formulations include (1) a high viscosity reactive oligomer (epoxy acrylate, urethane acrylate, polysiloxane acrylate), (2) a reactive diluent (mono or multiacrylate monomers), (3) a photoinitiator, and (4) an adhesion promoting agent. The final properties of the cured coating such as hardness, flexibility, toughness, abrasion, optical transparency, adhesion and glass transition (Ta) are determined directly by the chemistry and composition of the liquid formulation. There are several commercially available UV-curable materials to satisfy a variety of applications. All of these materials are highly toxic in the liquid state. We are therefore investigating formulations which contain no volatile components in order to reduce the hazards related to their removal. Ideally, a coating formulation would be one component, nonvolatile, highly reactive, sufficiently viscous, with good wetting to the substrate. In addition, the resulting coating should have the desired mechanical, optical and physical properties after curing under dynamic conditions (in a high speed fiber drawing operation). We would like to be able to tailor these properties simply by controlling the synthesis parameters of this one component system. A promising class of materials for this kind of "ideal" coating is inorganic-organic hybrid materials with organics chemically linked to inorganics. In particular, organically modified silicates were investigated. In the search for new UV curable materials combining both good optical and protective properties, we synthesized three different types of diacryloalkoxysilanes. Upon hydrolysis and partial condensation of alkoxysilyl groups, they formed viscous, one component UV-curable liquids containing photoinitiator. The acrylosilicate coatings were synthesized by the method used previously by Wolter et al.1 in which 3-mercaptopropyltrimethoxysilane was coupled via its S-H group to the C =C bond of the acrylic group of aliphatic triacrylate. Three commercially available triacrylates commonly used as reactive diluents in UV curing technology were O-8194-1339-9/94/$6.OO SPIE Vol. 2074 / 13

Multi-level selection and the issue of environmental homogeneity

In this paper, I identify two general positions with respect to the relationship between environment and natural selection. These positions consist in claiming that selective claims need and, respectively, need not be relativized to homogenous environments. I then show that adopting one or the other position makes a difference with respect to the way in which the effects of selection are to be measured in certain cases in which the focal population is distributed over heterogeneous environments. Moreover, I show that these two positions lead to two different interpretations – the Pricean and contextualist ones – of a type of selection scenarios in which multiple groups varying in properties affect the change in the metapopulation mean of individual-level traits. Showing that these two interpretations stem from different attitudes towards environmental homogeneity allows me to argue: a) that, unlike the Pricean interpretation, the contextualist interpretation can only claim that drift or selection is responsible for the change in frequency of the focal trait in a given metapopulation if details about whether or not group formation is random are specified; b) that the traditional main objection against the Pricean interpretation – consisting in arguing that the latter takes certain side-effects of individual selection to be effects of group selection – is unconvincing. This leads me to suggest that the ongoing debate about which of the two interpretations is preferable should concentrate on different issues than previously thought

Experimental investigations of ambiguity: the case of most

In the study of natural language quantification, much recent attention has been devoted to the investigation of verification procedures associated with the proportional quantifier most. The aim of these studies is to go beyond the traditional characterization of the semantics of most, which is confined to explicating its truth-functional and presuppositional content as well as its combinatorial properties, as these aspects underdetermine the correct analysis of most. The present paper contributes to this effort by presenting new experimental evidence in support of a decompositional analysis of most according to which it is a superlative construction built from a gradable predicate many or much and the superlative operator -est (Hackl, in Nat Lang Semant 17:63–98, 2009). Our evidence comes in the form of verification profiles for sentences like Most of the dots are blue which, we argue, reflect the existence of a superlative reading of most. This notably contrasts with Lidz et al.’s (Nat Lang Semant 19:227–256, 2011) results. To reconcile the two sets of data, we argue, it is necessary to take important differences in task demands into account, which impose limits on the conclusions that can be drawn from these studies

Cumulative readings of every do not provide evidence for events and thematic roles

An argument by Kratzer (2000) based on Schein (1986, 1993) does not conclusively show that events and thematic roles are necessary ingredients of the logical representation of natural language sentences. The argument claims that cumulative readings of every can be represented only with these ingredients. But scope-splitting accounts make it possible to represent cumulative readings of every in an eventless framework. Such accounts are motivated by obligatory reconstruction effects of every and by crosslinguistic considerations. Kratzer proposes that agent but not theme occurs in the logical representation of sentences because this allows her to model subject-object asymmetries in the distribution of cumulative every. But the reason for these asymmetries seems to be that every must be c-commanded by another quantifier in order to cumulate with it, no matter what its thematic role is. So the distribution of cumulative every does not provide support for Kratzer’s proposal

External representations and scientific understanding

This paper provides an inferentialist account of model-based understanding by combining a counterfactual account of explanation and an inferentialist account of representation with a view of modeling as extended cognition. This account makes it understandable how the manipulation of surrogate systems like models can provide genuinely new empirical understanding about the world. Similarly, the account pro- vides an answer to the question how models, that always incorporate assumptions that are literally untrue of the model target, can still provide factive explanations. Finally, the paper shows how the contrastive counterfactual theory of explanation can provide tools for assessing the explanatory power of models.Peer reviewe

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)